Columbia Laboratories, Inc. (CBRX) Narrows Q4 Loss by 5c/Share; Revs Lighten
Get Alerts CBRX Hot Sheet
Join SI Premium – FREE
Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q4 EPS of ($0.01), versus ($0.06) reported last year. Revenue for the quarter came in at $6.4 million, versus $14.9 million reported last year.
For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.
For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Primis Financial (FRST) Misses Q1 EPS by 8c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!